RxDoctor Payments Data

Albert Graziosa, MD

Orthopaedic Surgery · Bronx, NYNPI 1205927498

Payments from drug & device makers

$4,782in general payments, 2019–2025

Across 51 payments — averaging $93.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$4K
  • AbbVie$474
  • Amgen$237
  • Boston Scientific$169
  • Suvon Surgical LLC$111
  • Johnson & Johnson$23

What the payments were for

  • Travel & lodging$2,27948%
  • Food & beverage$2,47852%
  • Education$251%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew26$3,767
AbbVie6$474
Amgen16$237
Boston Scientific1$169
Suvon Surgical LLC1$111
Johnson & Johnson1$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,782 in reported general payments places this provider in the 50th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York

Medicare billing

Part B allowed, 2024
$42,213
Medicare patients
116
Services billed
424

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxepin Hcl32$22,261
Chlorpromazine Hcl26$20,635
Diclofenac Sodium26$7,480
Celecoxib22$218
Ibuprofen43$173
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen21$26
Cyclobenzaprine Hcl13$20

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Bronx

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →